Contrast Enhanced Voiding Urosonography with Urodynamic Testing ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 118 | 脊髄髄膜瘤 | 1 |
118. 脊髄髄膜瘤
臨床試験数 : 5 / 薬物数 : 7 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 10
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04738539 (ClinicalTrials.gov) | March 2, 2021 | 1/2/2021 | Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies | Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies | Myelomeningocele;Neurogenic Bladder;Tethered Cord Syndrome;Bladder, Neurogenic;Urologic Diseases;Neurologic Dysfunction | Drug: Contrast Enhanced Voiding Urosonography with Urodynamic Testing;Diagnostic Test: Urodynamic Testing | University of Virginia | NULL | Recruiting | N/A | 18 Years | All | 105 | United States |